Doximity, Inc. (DOCS)
NYSE: DOCS · IEX Real-Time Price · USD
28.03
+4.29 (18.07%)
At close: May 17, 2024, 4:00 PM
28.15
+0.12 (0.43%)
After-hours: May 17, 2024, 7:59 PM EDT
Doximity Revenue
Doximity had revenue of $468.33M in the twelve months ending December 31, 2023, with 16.58% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $135.28M with 17.37% year-over-year growth. In the fiscal year ending March 31, 2023, Doximity had annual revenue of $419.05M with 21.98% growth.
Revenue (ttm)
$468.33M
Revenue Growth
+16.58%
P/S Ratio
11.19
Revenue / Employee
$479,356
Employees
977
Market Cap
5.24B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 419.05M | 75.50M | 21.98% |
Mar 31, 2022 | 343.55M | 136.65M | 66.05% |
Mar 31, 2021 | 206.90M | 90.51M | 77.76% |
Mar 31, 2020 | 116.39M | 30.69M | 35.82% |
Mar 31, 2019 | 85.70M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.79B |
Perrigo Company | 4.56B |
PACS Group | 3.34B |
Alkermes | 1.73B |
RadNet | 1.66B |
TransMedics Group | 296.92M |
Alpine Immune Sciences | 56.52M |
Crinetics Pharmaceuticals | 1.97M |
DOCS News
- 3 hours ago - IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm - Accesswire
- 16 hours ago - DOXIMITY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS - PRNewsWire
- 1 day ago - Doximity Surges on Earnings Beat, Strong Outlook, Stock Buyback Announcement - Investopedia
- 1 day ago - DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm - Accesswire
- 1 day ago - DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit - PRNewsWire
- 1 day ago - Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results - Business Wire
- 2 days ago - ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS - PRNewsWire
- 2 days ago - Doximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP - PRNewsWire